Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: Measuring parents' and healthcare professionals' preferences

Journal of Clinical Oncology

Volumn 22, Issue 19, 2004, Pages 3922-3929

  Sung, Lillian ^a   Feldman, Brian M ^a   Schwamborn, Gina ^a   Paczesny, Diana ^a   Cochrane, Ashley ^a   Greenberg, Mark L ^a   Maloney, Anne Marie ^a   Hendershot, Eleanor I ^a   Naqvi, Ahmed ^a   Barrera, Maru ^a   Llewellyn Thomas, Hilary A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ANXIETY; ARTICLE; CONTROLLED STUDY; FEAR; FEBRILE NEUTROPENIA; HEALTH PRACTITIONER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PARENT; PRIORITY JOURNAL; QUALITY OF LIFE; AMBULATORY CARE; CHEMICALLY INDUCED DISORDER; CHILD; FEMALE; FEVER; HEALTH CARE PERSONNEL; HOSPITALIZATION; INFUSION; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADMINISTRATION, ORAL; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HEALTH PERSONNEL; HOSPITALIZATION; HUMANS; INFUSIONS, PARENTERAL; MALE; NEUTROPENIA; PARENTS;

EID: 5444274708     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.077     Document Type: Article

References (13)

1. Llewellyn-Thomas HA: Patients' healthcare decision making: A framework for descriptive and experimental investigations. Med Decis Making 15:101-106, 1995
2. Charles C, DeMaio S: Lay participation in health care decision making: A conceptual framework. J Health Polit Policy Law 18:881-904, 1993
3. Moore JB, Beckwitt AE: Parents' reactions to conflict with health care providers. West J Nurs Res 25:30-44, 2003
4. Olechnowicz JQ, Eder M, Simon C, et al: Assent observed: Children's involvement in leukemia treatment and research discussions. Pediatrics 109:806-814, 2002
5. Kunin H: Ethical issues in pediatric life-threatening illness: Dilemmas of consent, assent, and communication. Ethics Behav 7:43-57, 1997
6. Hughes WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751, 2002
7. Orudjev E, Lange BJ: Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 39:77-85, 2002
8. Paganini H, Rodriguez-Brieshcke T, Zubizarreta P, et al: Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. Cancer 91:1563-1567, 2001
9. Mullen CA, Petropoulos D, Roberts WM, et al: Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 86:126-134, 1999
10. Paganini H, Gomez S, Ruvinsky S, et al: Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: A single-center, randomized, controlled trial in Argentina. Cancer 97:1775-1780, 2003
11. Petrilli AS, Dantas LS, Campos MC, et al: Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial. Med Pediatr Oncol 34:87-91, 2000
12. Baorto EP, Aquino VM, Mullen CA, et al: Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 92:909-913, 2001
13. Castagnola E, Paola D, Giacchino R, et al: Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: A literature review. J Hematother Stem Cell Res 9:645-649, 2000